Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 19, 2005 02:15 ET | Source: Epigenomics AG

Epigenomics DNA Methylation Test Successfully Detects Colorectal Cancer in Blood

BERLIN, Germany and SEATTLE, Dec. 19, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced...
December 13, 2005 08:42 ET | Source: Epigenomics AG

Ad hoc: Milestone and Licensing Decision on Tamoxifen Response Test Postponed to End of January 2006

BERLIN, Germany and SEATTLE, Dec. 13, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX) (Other OTC:EPGNF), a molecular diagnostics company developing tests based on DNA methylation,...
November 15, 2005 02:37 ET | Source: Epigenomics AG

Epigenomics AG Announces End of VC Pooling

BERLIN and SEATTLE, Nov. 15, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that it has...
November 02, 2005 02:38 ET | Source: Epigenomics AG

Epigenomics AG Reports Third Quarter 2005 Financial Results

SEATTLE and BERLIN, Germany, Nov. 2, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported...
October 31, 2005 02:07 ET | Source: Epigenomics AG

Epigenomics Reports Tamoxifen Treatment Response Test Study Results Inconclusive

BERLIN, Germany and SEATTLE, Oct. 31, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today...
September 12, 2005 07:08 ET | Source: Epigenomics AG

Epigenomics AG Announces Resignation of Aron Braun

BERLIN, Sept. 12, 2005 (PRIMEZONE) -- Ad Hoc: Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, today announced that...
August 15, 2005 10:21 ET | Source: Epigenomics AG

Ad Hoc: Retiring Epigenomics Executive Gary Schweikhardt Released from Lock-Up at Year-End

BERLIN, Germany and SEATTLE, Aug. 15, 2005 (PRIMEZONE) -- Epigenomics AG (Other OTC:EPGNF), a molecular diagnostics company developing tests based on DNA methylation, today announced that Morgan...
August 03, 2005 02:51 ET | Source: Epigenomics AG

Epigenomics AG Reports Second Quarter and First Half 2005 Financial Results

BERLIN, Aug. 3, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported financial results for...
August 02, 2005 14:17 ET | Source: Epigenomics AG

Ad hoc: Epigenomics AG Announces Gary Schweikhardt to Retire

BERLIN, Germany, Aug. 02, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, today announced that,...
July 27, 2005 02:39 ET | Source: Epigenomics AG

Epigenomics AG Announces Second Quarter and First-Half 2005 Financial Results Conference Call

BERLIN, Germany, July 27, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that it will...